Thomas Edward Adams - 12 May 2025 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Role
Chief Financial Officer
Signature
/s/ Thomas Adams
Issuer symbol
KRMD
Transactions as of
12 May 2025
Net transactions value
$0
Form type
4
Filing time
11 Aug 2025, 16:24:02 UTC
Previous filing
21 Mar 2025
Next filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Adams Thomas Edward Chief Financial Officer C/O KORU MEDICAL SYSTEMS, INC., 100 CORPORATE DRIVE, MAHWAH /s/ Thomas Adams 07 Aug 2025 0001939226

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRMD Restricted Stock Units Award $0 +32,773 $0.000000 32,773 12 May 2025 Common Stock 32,773 Direct F1, F2, F3
transaction KRMD Restricted Stock Units Award $0 +32,773 $0.000000 32,773 12 May 2025 Common Stock 32,773 Direct F1, F2, F4
transaction KRMD Option to buy Common Stock Award $0 +55,583 $0.000000 55,583 12 May 2025 Common Stock 55,583 $3.21 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program.
F2 Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting.
F3 One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof or upon an earlier chance in control of the Company.
F4 These restricted stock units will vest based upon achievement of certain performance conditions as of December 31, 2027. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved, multiplied by between 0.5 to 1.5 times of the earned number of shares. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2027.
F5 One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof.

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.